Distal Radial Artery Access for Renal Denervation in Resistant Hypertension: A Case Report

Clicks: 1
ID: 315526
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #151 of 248 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 248 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstracts Background Renal denervation (RDN) has emerged as an effective interventional strategy to achieve sustained blood pressure reduction in patients with resistant hypertension. However, conventional access routes, including femoral and proximal radial arteries, may be associated with vascular complications and prolonged compression time. We report the first case of RDN performed via distal radial artery access. Case Summary A 55-year-old man with a 20-year history of poorly controlled hypertension despite quadruple antihypertensive therapy was admitted for worsening symptoms. Baseline imaging confirmed suitable renal artery anatomy. RDN was successfully performed through right distal radial artery access using a 6F sheath. A total of 60 radiofrequency ablation points were delivered to bilateral renal arteries without procedural complications. Hemostasis was achieved with 3 hours of compression. Although blood pressure transiently increased at 3 days post-procedure, progressive reduction was observed during follow-up. Mean 24-hour blood pressure decreased from 166/92 mmHg at 3 days to 153/89 mmHg at 3 months and further to 134/77 mmHg at 6 months. Antihypertensive therapy was reduced to single-drug treatment at 6 months. Conclusion Distal radial artery access for RDN is feasible and safe, providing favorable hemostasis and comparable therapeutic effect. This approach may represent a novel and patient-friendly alternative access strategy for the treatment of resistant hypertension.
Reference Key
openalex_W7163179327 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yuxin Zhao, Y U A N Du, Yang Tang, 于美群, Lijian Gao
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag402
URL
https://doi.org/10.1093/ehjcr/ytag402
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.